Paton J C, Andrew P W, Boulnois G J, Mitchell T J
Department of Microbiology, Adelaide Children's Hospital, Australia.
Annu Rev Microbiol. 1993;47:89-115. doi: 10.1146/annurev.mi.47.100193.000513.
For many years the virulence of Streptococcus pneumoniae has largely been attributed to its antiphagocytic polysaccharide capsule. Recent evidence, however, indicates that certain pneumococcal proteins play an important part in the pathogenesis of disease, either as mediators of inflammation or by directly attacking host tissues. Pneumococci carrying defined mutations in the genes encoding any one of at least three pneumococcal proteins (the toxin pneumolysin, the major pneumococcal autolysin, and pneumococcal surface protein A) have significantly reduced virulence. Pneumococcal hydrolytic enzymes, such as neuraminidase, hyaluronidase, and IgA1 protease may also contribute to colonization and/or invasion of the host. Several of these proteins (or their detoxified derivatives) are protective immunogens in animal models and therefore warrant consideration for inclusion in human antipneumococcal vaccine formulations.
多年来,肺炎链球菌的毒力很大程度上归因于其抗吞噬多糖荚膜。然而,最近的证据表明,某些肺炎球菌蛋白在疾病发病机制中起着重要作用,要么作为炎症介质,要么直接攻击宿主组织。在编码至少三种肺炎球菌蛋白(毒素肺炎溶血素、主要肺炎球菌自溶素和肺炎球菌表面蛋白A)中任何一种的基因中携带特定突变的肺炎球菌,其毒力显著降低。肺炎球菌水解酶,如神经氨酸酶、透明质酸酶和IgA1蛋白酶,也可能有助于宿主的定植和/或侵袭。这些蛋白中的几种(或其解毒衍生物)在动物模型中是保护性免疫原,因此值得考虑纳入人类抗肺炎球菌疫苗配方中。